✦ LIBER ✦

759 - Phase II study of 24 hours-infusion of 5-fluorouracil and high dose folinic acid in patients with progressive or recurrent colorectal cancer (CRC)

✍ Scribed by J.T. Hartmann; C.H. Köhne; H.-J. Schmoll; C. Kollmannsberger; L. Kanz; C Bokemeyer

Book ID: 117665005
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 269 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)85388-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of paclitaxel, weekly,

A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

✍ Kollmannsberger, C; Quietzsch, D; Haag, C; Lingenfelser, T; Schroeder, M; Hartma 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 68 KB

Randomized phase III Study of 5-fluorour

Randomized phase III Study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer

✍ Dennie V. Jones; Roger J. Winn; Barry W. Brown; Lawrence B. Levy; Reginald P. Pu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Background. Metastatic colorectal cancer is generally incurable. The most active regimen available, 5-fluorouracil(5-FU) and folinic acid (Leucovorin), produces response rates of approximately 25% to 30%. Methyl-lomustine is a nitrosourea with modest activity against colorectal cancer. A randomized

Phase III trial of bolus 5-fluorouracil

Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)

✍ A. Grothey; T. Buechele; H. Kroening; K. Ridwelski; P. Reichardt; A. Kretzschmar 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Phase II study of weekly oxaliplatin and

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer

✍ Chao, Y; Yeh, K H; Chang, C J; Chen, L T; Chao, T Y; Wu, M F; Chang, C S; Chang, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

High dose 5-fluorouracil (5-FU) and foli

High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: Results of a phase II study

✍ E. Jäger; O. Klein; B. Wächter; B. Müller; U. Braun; A. Knuth 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Plasma and salivary pharmacokinetics of

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid

✍ J.M Joulia; F Pinguet; M Ychou; J Duffour; C Astre; F Bressolle 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 120 KB